Abbott Laboratories Share Price Wiener Boerse
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Wiener Boerse
09/10/2026
|
5-day change | 1st Jan Change | ||
| 88.96 EUR | +2.28% |
|
+3.39% | -16.04% |
| 09/10 | Trump Disclosed 517 Securities Transactions in August, Including Up to $25 Million Meta Purchase | MT |
| 07/10 | Abbott Introduces Ensure Max Protein 3-In-1 Muscle Support Protein Powder | CI |
| Market Cap | 17TCr 15TCr 14TCr 13TCr 25TCr 16,68000Cr 25TCr 1,72300Cr 68TCr 8,50400Cr 65TCr 63TCr 27,28900Cr | P/E 2026 * |
29.2x | P/E 2027 * | 22.6x |
|---|---|---|---|---|---|
| Enterprise Value | 20TCr 18TCr 16TCr 15TCr 28TCr 18,99700Cr 28TCr 1,96300Cr 77TCr 9,68500Cr 74TCr 72TCr 31,08000Cr | EV / Sales 2026 * |
3.91x | EV / Sales 2027 * | 3.54x |
| Free-Float |
86.16% | Yield 2026 * |
2.58% | Yield 2027 * | 2.75% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
|
Xetra
| ABL | Delayed | |
|
London S.E.
| ABT | Delayed | |
|
Boerse Muenchen
| ABL | Real-time | |
|
Tradegate
| ABL | Real-time | |
|
CBOE
| ABT | Real-time | |
|
Borsa Italiana
| 1ABT | End-of-day quote | |
|
Mexican S.E.
| ABT * | End-of-day quote | |
|
CBOE
| Real-time | ||
|
Kazakhstan S.E.
| ABT_KZ | End-of-day quote | |
|
Lima
| ABTUS | End-of-day quote | |
|
Wiener Boerse
| ABT | End-of-day quote | |
|
Swiss Exchange
| ABT | Delayed | |
|
Santiago S.E.
| ABTCL | End-of-day quote | |
|
Deutsche Boerse AG
| ABL | Delayed | |
|
Börse Stuttgart
| ABL | Delayed | |
|
Santiago S.E.
| ABT | End-of-day quote |
Last Transcript: Abbott Laboratories
| 1 day | +2.28% | ||
| 1 week | +3.39% | ||
| Current month | +0.88% | ||
| 1 month | -0.87% | ||
| 3 months | +8.12% | ||
| 6 months | +3.66% | ||
| Current year | -16.04% |
| 1 week | 86.98 |  | 89.54 |
| 1 month | 85.96 | | 91.26 |
| Current year | 70.1 | | 109.64 |
| 1 year | 70.1 | | 115.8 |
| 3 years | 70.1 | | 134.2 |
| 5 years | 70.1 | | 134.2 |
| 10 years | 49.6 | | 134.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.28% | +3.39% | - | - | 17TCr | |
| +1.13% | +2.15% | -24.87% | +2.09% | 17TCr | |
| +0.83% | +2.43% | -7.30% | +16.15% | 11TCr | |
| +0.13% | +0.69% | -23.94% | +1.05% | 11TCr | |
| +2.34% | +2.49% | -46.47% | -11.84% | 7.53TCr | |
| +0.78% | +4.79% | +1.84% | +72.29% | 6.18TCr | |
| +0.12% | +3.62% | +15.06% | +65.87% | 5.29TCr | |
| +0.55% | +3.93% | -1.51% | -31.24% | 5.01TCr | |
| +0.95% | -0.08% | -15.93% | +14.93% | 4.08TCr | |
| +1.45% | +1.83% | - | - | 3.18TCr | |
| Average | +1.06% | +2.31% | -12.89% | +16.16% | 7.83TCr | |
| Weighted average by Cap. | +1.18% | +2.24% | -16.31% | +12.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.02TCr 4.48TCr 4.17TCr 3.79TCr 7.16TCr 4,85900Cr 7.19TCr 50TCr 20TCr 2,47700Cr 19TCr 18TCr 7,94900Cr | 5.45TCr 4.87TCr 4.53TCr 4.12TCr 7.78TCr 5,27800Cr 7.81TCr 55TCr 21TCr 2,69100Cr 20TCr 20TCr 8,63500Cr |
| Net income | 621.22Cr 554.82Cr 516.12Cr 469.45Cr 886.38Cr 60TCr 890.21Cr 6.21TCr 2.43TCr 31TCr 2.33TCr 2.28TCr 98TCr | 789.36Cr 704.98Cr 655.81Cr 596.51Cr 1.13TCr 76TCr 1.13TCr 7.89TCr 3.09TCr 39TCr 2.96TCr 2.9TCr 1,25000Cr |
| Net Debt | 2.39TCr 2.14TCr 1.99TCr 1.81TCr 3.42TCr 2,31700Cr 3.43TCr 24TCr 9.38TCr 1,18100Cr 8.99TCr 8.79TCr 3,79100Cr | 2.1TCr 1.87TCr 1.74TCr 1.58TCr 2.99TCr 2,02800Cr 3TCr 21TCr 8.21TCr 1,03400Cr 7.87TCr 7.7TCr 3,31800Cr |
| Date | Price | Change |
|---|---|---|
| 09/26/09 | €88.96 | +2.28% |
| 08/26/08 | €86.98 | -0.80% |
| 07/26/07 | €87.68 | -0.57% |
| 06/26/06 | €88.18 | -1.19% |
| 05/26/05 | €89.24 | +3.72% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
